Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Mosapride Citrate

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 376Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 112885-42-4, Gasmotin, As-4370, Mosapride (citrate), Tak-370, Rimopride citrate
    Molecular Formula
    C27H33ClFN3O10
    Molecular Weight
    614.0  g/mol
    InChI Key
    HUZTYZBFZKRPFG-UHFFFAOYSA-N
    FDA UNII
    MF497J489P
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide;2-hydroxypropane-1,2,3-tricarboxylic acid
    2.1.2 InChI
    InChI=1S/C21H25ClFN3O3.C6H8O7/c1-2-28-20-10-19(24)18(22)9-17(20)21(27)25-11-16-13-26(7-8-29-16)12-14-3-5-15(23)6-4-14;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-6,9-10,16H,2,7-8,11-13,24H2,1H3,(H,25,27);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
    2.1.3 InChI Key
    HUZTYZBFZKRPFG-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
    2.2 Other Identifiers
    2.2.1 UNII
    MF497J489P
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 4-amino-5-chloro-2-ethoxy-n-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide

    2. As 4370

    3. As-4370

    4. Mosapride

    5. Mosapride Ui05msp015ct

    2.3.2 Depositor-Supplied Synonyms

    1. 112885-42-4

    2. Gasmotin

    3. As-4370

    4. Mosapride (citrate)

    5. Tak-370

    6. Rimopride Citrate

    7. 4-amino-5-chloro-2-ethoxy-n-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide 2-hydroxypropane-1,2,3-tricarboxylate

    8. Gasmot

    9. Mf497j489p

    10. Dsstox_cid_26207

    11. Dsstox_rid_81436

    12. Dsstox_gsid_46207

    13. 4-amino-5-chloro-2-ethoxy-n-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide Citrate

    14. Cas-112885-42-4

    15. C21h25clfn3o3.c6h8o7

    16. Unii-mf497j489p

    17. Gasmotin Citrate

    18. Tak-370 Citrate

    19. As-4370 Citrate

    20. Mosapride Citrate- Bio-x

    21. (+-)-4-amino-5-chloro-2-ethoxy-n-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide Citrate

    22. Mls006011997

    23. Schembl258620

    24. Mosapride Citrate [mi]

    25. Tak370

    26. Chembl1733174

    27. Dtxsid7046207

    28. Hy-b0189a

    29. Amy8852

    30. Tak 370

    31. Hms2051p15

    32. Hms2234k07

    33. Hms3369k19

    34. Hms3393p15

    35. Hms3651o09

    36. Hms3884e13

    37. Mosapride Citrate [who-dd]

    38. Bcp08880

    39. Tox21_111874

    40. Mfcd01666680

    41. Mosapride Citrate - Adooq Bioscience

    42. S1385

    43. Akos015895400

    44. Tox21_111874_1

    45. Ccg-100966

    46. Ccg-270241

    47. Nc00216

    48. Ncgc00160527-03

    49. As-13388

    50. Benzamide, 4-amino-5-chloro-2-ethoxy-n-((4-((4-fluorophenyl)methyl)-2-morpholinyl)methyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)

    51. Bm164611

    52. Sw197596-2

    53. 85m424

    54. D70344

    55. A921736

    56. Q27283985

    57. (+/-)-4-amino-5-chloro-2-ethoxy-n-((4-(p-fluorobenzyl)-2-morpholinyl)methyl)benzamide Citrate

    58. 4-amino-5-chloro-2-ethoxy-n-[[4-[(4 -fluorophenyl)methyl]-2-morpholinyl]methyl]benzami De Citrate

    59. 4-amino-5-chloro-2-ethoxy-n-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide Citrate

    60. 4-amino-5-chloro-2-ethoxy-n-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide;2-hydroxypropane-1,2,3-tricarboxylic Acid.

    61. Tak-370 Citrate; As-4370 Citrat;tak370 Citrate; As4370 Citrat;tak 370 Citrate; As 4370 Citrat

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 614.0 g/mol
    Molecular Formula C27H33ClFN3O10
    Hydrogen Bond Donor Count6
    Hydrogen Bond Acceptor Count13
    Rotatable Bond Count12
    Exact Mass613.1838501 g/mol
    Monoisotopic Mass613.1838501 g/mol
    Topological Polar Surface Area209 Ų
    Heavy Atom Count42
    Formal Charge0
    Complexity749
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count1
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Serotonin Receptor Agonists

    Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)

    Gastrointestinal Agents

    Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)